Evidence map›Paper›PMID 36439817›Full record

ArticleFrontiers in microbiology2022

Coexistence of

Muhammad Shafiq, Mi Zeng, Budi Permana, Hazrat Bilal, Jinhu Huang, Fen Yao, Abdelazeem Mohamed Algammal, Xin Li, Yumeng Yuan, Xiaoyang Jiao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. First record of methicillin-resistantNew microbes and new infections · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Muhammad ShafiqDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Mi ZengDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Budi PermanaSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD, Australia.
Hazrat BilalDepartment of Dermatology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Jinhu HuangMinistry of Education (MOE) Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
Fen YaoDepartment of Pharmacology, Shantou University Medical College, Shantou, China.
Abdelazeem Mohamed AlgammalDepartment of Bacteriology, Immunology, and Mycology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
Xin LiDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Yumeng YuanDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Xiaoyang JiaoDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Shantou University · CNNanjing Agricultural University · CNShantou University Medical College · CNSuez Canal University · EGUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of pathogens is conferring resistance to last-resort therapies such as tigecycline, colistin, and carbapenems, limiting the therapeutic options, and raising concerns about the emergence of new "superbugs." This study reports the first incident of a

Indexed as

antimicrobial resistanceblaNDM–5coexistenceEscherichia colihybrid plasmidssuperbugstet(X4)

Identifiers

PMID36439817
PMCPMC9685555
OpenAlexW4308878213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.